HealthEquity (HQY)
(Delayed Data from NSDQ)
$86.20 USD
+1.90 (2.25%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $86.17 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
HQY 86.20 +1.90(2.25%)
Will HQY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HQY
Here's Why You Should Retain HealthEquity (HQY) Stock for Now
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Other News for HQY
Healthequity Shareholders Approve Key Proposals at Annual Meeting
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
TimesSquare Capital U.S. Small/Mid Cap Growth Q1 2024 Commentary
Demystifying HealthEquity: Insights From 11 Analyst Reviews
Healthequity (HQY) Receives a Buy from Wells Fargo